Company Profile
- Company name
- Jiksak Bioengineering, Inc.
- Address
- CYBERNICS MEDICAL INNOVATION BASE-A room 322
3-25-16 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-0821, Japan
- Established
- February 7, 2017
- Business Description
- Development, manufacture, and sales of 3D cell tissue and culture devices;
Drug discovery services using human-derived cells
History
| Date |
Event |
| Feb 2017 |
Established in Tokyo under NEDO’s startup program |
| Jan 2018 |
Nakatsuji Award from Kyoto SMI (CEO Kawada) |
| Feb 2018 |
Selected for Ogasawara Science and Technology Foundation Incubation Project |
| Aug 2018 |
Chosen for IPAS, a support program by the Japan Patent Office |
| Oct 2018 |
Head office relocated to Kawasaki to expand research facilities |
| Oct 2018 |
Received INNOvation award from Ministry of Internal Affairs and Communications |
| Feb 2019 |
Awarded 2019 Innovation Award from Kanagawa Business Audition (KBA) |
| Apr 2019 |
Began production of 3D Nerve Organoids |
| Mar 2020 |
Collaboration with Professor Shinsuke Shibata research project supported by AMED Center for Research Center Network for Realization of Regenerative Medicine at Keio University
|
| Feb 2021 |
Acquired Series B funding |
| Aug 2021 |
Collaboration with Professor Shinsuke Shibata research project supported by Advanced Research and Development Programs for Medical Innovation (AMED-CREST, PRIME) at Niigata University |
| Oct 2021 |
Selected to participate in Tokyo’s Advanced Medical Devices Acceleration Program (AMDAP) |
| Aug 2022 |
Acquired Series B funding |
| Jul 2023 |
The head office was relocated to KING SKYFRONT in Kawasaki city to expand our research facilities |
Leadership
Jiro Kawada,Ph.D.
Representative Director, co-CEO
Jiro Kawada is the founder and co-CEO of Jiksak Bioengineering. Prior to founding Jiksak in 2017 to apply nerve organoid technology to ALS drug discovery, he conducted research on microfluidics and stem cell culture for 9 years. Dr. Kawada obtained his Ph.D. in engineering at the University of Tokyo.
Norihiro Yumoto, Ph.D.
Director, co-CEO
Norihiro Yumoto is the co-CEO of Jiksak Bioengineering. He joined the company as CTO in July 2018 before assuming the current position. Prior to joining Jiksak, he worked in the Medical Affairs Department at AstraZeneca. Dr. Yumoto researched the neuromuscular junction for 8 years at New York University Medical Center. His paper on retrograde presynaptic differentiation signals from skeletal muscle to motor nerves was published in Nature in 2012. Dr. Yumoto obtained his Ph.D. in Molecular Medicine from Kyoto University, Graduate School of Medicine.
Masahiro Samejima
External Director
ANRI VC Fund
Yoshiho Ikeuchi
Associate Professor; Institute of Industrial Science, The University of Tokyo
Haruhiko Kamada
Project Leader; Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition
